PRNP and scrapie: Taken together, the obtained results demonstrate that a homologous chimeric VLP-based PrP vaccine can abrogate host encoded immune tolerance to cellular PrPC and induces an albeit weak antibody response that prolongates survival time in scrapie infected mice.